Stratmann GC - Search Results

1

Protease "Clipsin" activity and beta-amyloid precursor protein degradation by Alzheimer brain.

Stratmann GC, Webster MT, Bhogal G, Francis PT, Bowen DM. Stratmann GC, et al. Biochem Soc Trans. 1993 Aug;21 ( Pt 3)(3):241S. doi: 10.1042/bst021241s. Biochem Soc Trans. 1993. PMID: 8224397 No abstract available.

2

Protease 'Clipsin' extract activity reflects demographic characteristics of human brain.

Stratmann GC, Webster MT, Francis PT, Procter AW, Bowen DM. Stratmann GC, et al. Neurosci Lett. 1992 Aug 31;143(1-2):43-7. doi: 10.1016/0304-3940(92)90229-z. Neurosci Lett. 1992. PMID: 1436680

3

beta-Amyloid precursor protein isoforms show correlations with neurones but not with glia of demented subjects.

Procter AW, Francis PT, Holmes C, Webster MT, Qume M, Stratmann GC, Doshi R, Mann DM, Harrison PJ, Pearson RC, et al. Procter AW, et al. Among authors: stratmann gc. Acta Neuropathol. 1994;88(6):545-52. doi: 10.1007/BF00296491. Acta Neuropathol. 1994. PMID: 7879601

4

Brain membrane serine protease activity in human cortex compared with rat: implication for Alzheimer's disease.

Stratmann GC, Webster MT, Francis PT, Procter AW, Bowen DM. Stratmann GC, et al. Dementia. 1994 Mar-Apr;5(2):62-8. doi: 10.1159/000106699. Dementia. 1994. PMID: 8038868

5

Postmortem brains reveal similar but not identical amyloid precursor protein-like immunoreactivity in Alzheimer compared with other dementias.

Webster MT, Francis PT, Procter AW, Stratmann GC, Doshi R, Mann DM, Bowen DM. Webster MT, et al. Among authors: stratmann gc. Brain Res. 1994 May 2;644(2):347-51. doi: 10.1016/0006-8993(94)91702-7. Brain Res. 1994. PMID: 8050048

6

Serotonergic pathology is not widespread in Alzheimer patients without prominent aggressive symptoms.

Procter AW, Francis PT, Stratmann GC, Bowen DM. Procter AW, et al. Among authors: stratmann gc. Neurochem Res. 1992 Sep;17(9):917-22. doi: 10.1007/BF00993268. Neurochem Res. 1992. PMID: 1357564

7

Possible neurotransmitter basis of behavioral changes in Alzheimer's disease.

Palmer AM, Stratmann GC, Procter AW, Bowen DM. Palmer AM, et al. Among authors: stratmann gc. Ann Neurol. 1988 Jun;23(6):616-20. doi: 10.1002/ana.410230616. Ann Neurol. 1988. PMID: 2457353

8

Reduced glycine stimulation of [3H]MK-801 binding in Alzheimer's disease.

Procter AW, Wong EH, Stratmann GC, Lowe SL, Bowen DM. Procter AW, et al. Among authors: stratmann gc. J Neurochem. 1989 Sep;53(3):698-704. doi: 10.1111/j.1471-4159.1989.tb11760.x. J Neurochem. 1989. PMID: 2569500

9

Topographical distribution of neurochemical changes in Alzheimer's disease.

Procter AW, Lowe SL, Palmer AM, Francis PT, Esiri MM, Stratmann GC, Najlerahim A, Patel AJ, Hunt A, Bowen DM. Procter AW, et al. Among authors: stratmann gc. J Neurol Sci. 1988 Apr;84(2-3):125-40. doi: 10.1016/0022-510x(88)90118-9. J Neurol Sci. 1988. PMID: 2898011

10

Cholinomimetics increase glutamate outflow via an action on the corticostriatal pathway: implications for Alzheimer's disease.

Dijk SN, Francis PT, Stratmann GC, Bowen DM. Dijk SN, et al. Among authors: stratmann gc. J Neurochem. 1995 Nov;65(5):2165-9. doi: 10.1046/j.1471-4159.1995.65052165.x. J Neurochem. 1995. PMID: 7595503

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

19 results

Search Page

Filters